Technology companies living under the constant threat of patent litigation are increasingly inking cross-licensing deals and generating a broad mix of patent and transactional work for attorneys.
Attorneys say cross-licenses, which are comprehensive or limited rights to use another company’s patent technology, are particularly favored by biotechnology and information-technology companies as a way to avoid or settle litigation.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]